MedTrace Logo

Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring

NCT05526170 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 182

Last updated 2024-06-26

No results posted yet for this study

Summary

A prospective cohort study to evaluate the association between various triggers encountered in daily life and induction of atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia and premature atrial contractions) with the use of long-term monitoring devices. The collected data of personalized triggers and risk factors will be used to define the individual phenotype of atrial arrhythmia.

Conditions

  • Atrial Fibrillation
  • Atrial Flutter
  • Atrial Arrhythmia
  • Atrial Tachycardia
  • Premature Atrial Contractions
  • Arterial Hypertension
  • Sleep Disorder
  • Sleep Apnea
  • Stress
  • Physical Inactivity
  • Overexertion
  • Alcohol Drinking
  • Caffeine Dependence

Interventions

DEVICE

Devices for long-term monitoring of objective and subjective parameters of the body

Patients will use a 1-lead Holter ECG (Bittium Faros) for heart rhythm and physical activity analysis, a wearable wrist-worn device with photoplethysmography and 6-lead ECG for heart rhythm analysis, a sleep tracking mat (Withings sleep analyser) for sleep analysis, a smartphone with triggers application for entering the subjective triggers (stress, coffee, alcohol intake and others), a 48-hour ambulatory blood pressure monitor for 2 days and a regular blood pressure monitor for up to 5 days. Patients will be monitored for up to 7 days with the described system of devices. In addition, patients will receive investigations of heart echocardiography, laboratory tests and surveys to evaluate the system and the use of acquired information.

Sponsors & Collaborators

  • Kaunas University of Technology

    collaborator OTHER

  • Vilnius University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2024-07-15
Completion
2024-09-30

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526170 on ClinicalTrials.gov